Effects of recombinant growth hormone on visceral fat accumulation: Pilot study in human immunodeficiency virus-infected adolescents

Journal of Clinical Endocrinology and Metabolism

Volumn 90, Issue 7, 2005, Pages 4075-4080

  Viganò, Alessandra ^a   Mora, Stefano ^b   Manzoni, Paola ^a   Schneider, Laura ^a   Beretta, Silvia ^a   Molinaro, Mariadelfina ^c   Di Natale, Berardo ^a   Brambilla, Paolo ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b SAN RAFFAELE HOSPITAL   (Italy)

^c FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CHOLESTEROL; GLUCOSE; HUMAN GROWTH HORMONE; LAMIVUDINE; LIPID; PROTEINASE INHIBITOR; RECOMBINANT GROWTH HORMONE; STAVUDINE; TRIACYLGLYCEROL;

ADOLESCENT; ADULT; ARM; ARTICLE; BODY COMPOSITION; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; GLUCOSE METABOLISM; HEIGHT; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LEG; LIPID METABOLISM; LIPODYSTROPHY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OPEN STUDY; PEDIATRICS; PRIORITY JOURNAL; PROSPECTIVE STUDY; TRIACYLGLYCEROL BLOOD LEVEL;

ADIPOSE TISSUE; ADOLESCENT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BODY COMPOSITION; CHOLESTEROL; FEMALE; GROWTH HORMONE; HIV INFECTIONS; HUMANS; INSULIN-LIKE GROWTH FACTOR I; LIPODYSTROPHY; MALE; PILOT PROJECTS; TRIGLYCERIDES;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 23044432528     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2004-2431     Document Type: Article

References (37)

1. HIV Lipodystrophy Case Definition Study Group 2003 An objective case definition of lipodystrophy in HIV-infected adults: a case-control study. Lancet 361:726-735
2. Schambelan M, Benson CA, Carr A, Currier JS, Dube MP, Gerber JG, Grinspoon SK, Grunfeld C, Kotler DP, Mulligan K, Powderly WG, Saag MS, International AIDS Society-USA 2002 Management of metabolic complications associated with antiretroviral therapy for HIV-1 infection: recommendations of an International AIDS Society-USA Panel. J Acquir Immune Defic Syndr 31:257-275
3. European Paediatric Lipodystrophy Group 2004 Antiretroviral therapy, fat redistribution and hyperlipidaemia in HIV-infected children in Europe. AIDS 18:1443-1451
4. Brambilla P, Bricalli D, Sala N, Renzetti F, Manzoni P, Vanzulli A, Chiumello G, di Natale B, Viganò A 2001 Highly active antiretroviral-treated HIV-infected children show fat distribution changes even in absence of lipodystrophy. AIDS 15:2415-2422
5. Viganò A, Mora S, Testolin C, Becio S, Schneider L, Bricalli D, Vanzulli A, Manzoni P, Brambilla P 2003 Increased lipodystrophy is associated with increased exposure to highly active antiretroviral therapy in HIV-infected children. J Acquir Immune Defic Syndr 32:482-489
6. Arpadi SM, Cuff PA, Horlick M, Wang J, Kotler DP 2001 Lipodystrophy in HIV-infected children is associated with high viral load and low CD4+-lymphocyte count and CD4+-lymphocyte percentage at baseline and use of protease inhibitors and stavudine. J Acquir Immune Defic Syndr 27:30-34
7. Jaquet D, Levine M, Ortega-Rodriguez E, Faye A, Polak M, Vilmer E, Levy-Marchal C 2000 Clinical and metabolic presentation of the lipodystrophic syndrome in HIV-infected children. AIDS 14:2123-2128
8. Goran MI, Gower BA 1999 Relation between visceral fat and disease risk in children and adolescents. Am J Clin Nutr 70:149S-156S
9. Snel YE, Brummer RJ, Doerga ME, Zelissen PM, Bakker CJ, Hendriks MJ, KoppeschaarHP1995 Adipose tissue assessed by magnetic resonance imaging in growth hormone-deficient adults: the effect of growth hormone replacement and a comparison with control subject. Am J Clin Nutr 61:1290-1294
10. Cuneo RC, Judd S, Wallance JD, Perry-Keene D, Burger H, Lim-Tio S, Strauss B, Stockigt J, Topliss D, Alford F, Hew L, Bode H, Conway A, Handelsman D, Dunn S, Boyages S, Cheung NW, Hurley D 1998 The Australian Multicenter Trial of Growth Hormone (GH) Treatment in GH-Deficient Adults. J Clin Endocrinol Metab 83:107-116
11. Caroll PV, Christ ER, Bengtsson BA, Carlsson L, Christiansen JS, Clemmons D, Hintz R, Ho K, Laron Z, Sizonenko P, Soksen PH, Tanaka T, Thorne M 1998 Growth hormone deficiency in adulthood and effects of growth hormone replacement: a review. Growth Hormone Research Society Scientific Committee. J Clin Endocrinol Metab 83:382-395
12. Attanasio AF, Lamberts SW, Matranga AM, Birkett MA, Bates PC, Valk NK, Hilsted J, Bengtsson BA, Strasburger CJ 1997 Adult growth hormone (GH)-deficiency patients demonstrate heterogeneity between childhood onset and adult onset before and during human GH treatment. J Clin Endocrinol Metab 82:82-88
13. Rietschel P, Hadigan C, Corcoran C, Stanley T, Neubauer G, Gertner J, Grinspoon S 2001 Assessment of growth hormone dynamics in human immunodeficiency virus-related lipodystrophy. J Clin Endocrinol Metab 86:504-510
14. Viganò A, Mora S, Brambilla P, Schneider L, Merlo M, Monti LD, Manzoni P 2003 Impaired growth hormone secretion correlates with visceral adiposity in highly active antiretroviral treated HIV-infected adolescents. AIDS 17:1435-1441
15. Lo JC, Mulligan K, Noor MA, Schwarz JM, Halvorsen RA, Grunfeld C, Schambelan M 2001 The effects of recombinant human growth hormone on body composition and glucose metabolism in HIV-infected patients with fat accumulation. J Clin Endocrinol Metab 86:3480-3487
16. Engelson ES, Glesby MJ, Mendez D, Albu JB, Wang J, Heymsfield SB, Kotler DP 2002 Effect of recombinant human growth hormone in the treatment of visceral fat accumulation in HIV infection. J Acquir Immune Defic Syndr 30:379-391
17. Kotler DP, Muurahainen N, Grunfeld C, Wanke C, Thomson M, Saag M, Bock D, Simons G, Gertner JM, Serostim in Adipose Redistribution Syndrome Study Group 2004 Effects of growth hormone on abnormal visceral adipose tissue accumulation and dyslipidemia in HIV-infected patients. J Acquir Immune Defic Syndr 35:239-252
18. Albertsson-Wikland K, Rosberg S, Karlberg J, Groth T 1994 Analysis of 24 h GH profiles in healthy boys and girls of normal stature: relation to puberty. J Clin Endocrinol Metab 78:1195-1201
19. Lohman TG, Roche AF, Martorell R 1988 Anthropometrical standardization reference manual. Champaign IL: Human Kinetics Books
20. Brambilla P, Bosio L, Manzoni P, Pietrobelli A, Beccaria L, ChiumelloG1997 Peculiar body composition in patients with Prader-Labhart-Willi syndrome. Am J Clin Nutr 65:1369-1374
21. Van der Kooy K, Seidell JC 1993 Techniques for the measurement of visceral fat: a practical guide. Int J Obes 17:187-196
22. Matthews DR, Hosker JP, Naylor BA, Treacher DF, Turner RC 1985 Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412-419
23. Alberti KGMM; Zimmet PZ 1998 Definition, diagnosis and classification of diabetes mellitus and its complications. Part I: diagnosis and classification of diabetes mellitus. Provisional report of a WHO Consultation. Diabet Med 15:539-553
24. Tanner JM, Whitehouse RH 1976 Clinical longitudinal standards for height, weight, height velocity and weight velocity and stages of puberty. Arch Dis Child 51:170-179
25. Brabant G, von zur Muhlen A, Wuster C, Ranke MB, Kratzsch J, Kiess W, Ketelslegers JM, Wilhelmsen L, Hulthen L, Saller B, Mattsson A, Wilde J, Schemer R, Kann P, German KIMS Board 2003 Serum insulin-like growth factor I reference values for an automated chemiluminescence immunoassay system: results from a multicenter study. Horm Res 60:53-60
26. American Diabetes Association 2000 Clinical practice recommendations. Diabetes Care 23:S20-S23
27. Christensen B, Glueck C, Kwiterovich P, Degroot I, Chase G, Heiss G, Mowery R, Tamir I, Rifkind B 1980 Plasma cholesterol and triglyceride distributions in 13,665 children and adolescents: the prevalence study of the lipid research clinics program. Pediatr Res 14:194-202
28. He Q, Horlick M, Fedun B, Wang J, Pierson RN, Heshka S, Gallagher D 2002 Trunk fat and blood pressure in children through puberty. Circulation 105:1093-1098
29. Koutkia P, Canavan B, Breu J, Torriani M, Kissko J, Grinspoon S 2005 Growth hormone-releasing hormone in HIV-infected men with lipodystrophy. A randomized controlled trial. JAMA 292:210-218
30. Fomon SJ, Hoschke F, Ziegler EE, Nelson SE 1982 Body composition of reference children from birth to age 10 years. Am J Clin Nutr 35:1169-1175
31. Lo JC, Mullighan K, Noor MA, Lee GA, Schwartz JM, Grunfeld C, Schambelan M 2004 The effects of low-dose growth hormone in HIV-infected men with fat accumulation: a pilot study. Clin Infect Dis 39:732-735
32. Saggese G, Ranke MB, Saenger P, Rosenfeld R, Tanaka T, Chaussain JL, Savage MO 1998 Diagnosis and treatment of growth hormone deficiency in children and adolescents: toward a consensus. Horm Res 50:320-340
33. Drake WM, Howell SJ, Monson JP, Shalet SM 2001 Optimizing GH therapy in adults and children. Endocr Rev 22:425-450
34. Leschek EW, Rose SR, Yanovski JA, Troendle JF, Quingley CA, Chipman JJ, Crowe BJ, Ross JL, Cassorla FG, Blum WF, Cutler Jr GB, Baron J, National Institute of Child Health and Human Development-Eli Lilly, Co. Growth Hormone Collaborative Group 2004 Effect of growth hormone treatment on adult height in peripubertal children with idiopathic short stature: a randomized, double-blind, placebo-controlled trial. J Clin Endocrinol Metab 89:3140-3148
35. Wit JM, Rekers-Mombarg LTM, Cutler GB, Crowe B, Beck TJ, Roberts K, Gill A, Chaussain J-L, Frisch H, Yturriaga R, Attanasio AF 2005 Growth hormone (GH) treatment to final height in children with idiopathic short stature: evidence for a dose effect. J Pediatr 146:45-53
36. Darendeliler F, Ranke MB, Bakker B, Lindberg A, Cowell CT, Albertsson-Wikland K, Reiter EO, Price DA 2005 Bone age progression during the first year of growth hormone therapy in pre-pubertal children with idiopathic growth hormone deficiency, Turner syndrome or idiopathic short stature, and in short children born small for gestational age: analysis of data from KIGS (Pfizer International Growth Database). Horm Res 63:40-47
37. Johannsson G, Marin P, Lonn L, Ottosson M, Stenlof K, Bjorntorp P, Sjostrom L, Bengtsson BA 1997 Growth hormone treatment of abdominally obese men reduces abdominal fat mass, improves glucose and lipoprotein metabolism and reduces diastolic blood pressure. J Clin Endocrinol Metab 82:727-734